The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List


Tue, Mar 4, 10:00 AM, Zacks
Synageva 4Q Loss Narrower-than-Expected Loss - Analyst Blog
Synageva BioPharma Corp. (GEVA) reported fourth quarter 2013 loss of $1 per share, wider than the year-ago loss of 62 cents per share, but narrower than the Zacks Consensus Estimate of a loss of $1.02 per share.

Thu, Feb 20, 8:21 AM, Zacks
Synageva BioPharma Corp. (GEVA) in Focus: Stock Moves 5.1% Higher - Tale of the Tape
Synageva BioPharma Corp. (GEVA) was a big mover last session, as the company saw its shares rise by over 5% on the day.

FREE registration required to continue...

You have viewed 6 pages within the last 6 hours. To continue, please register at The Online Investor for unlimited page views and our free weekly newsletter, by entering your name and email address below. Registration is absolutely free. By registering, you agree to the terms of our privacy policy, disclaimer, & terms of service.

Problems with your registration ''sticking?'' Enable your browser to receive our ''cookie'' to resolve. Other questions? Email us at:

Synageva BioPharma Corp (GEVA) Page | The Online Investor | | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.